Nexgel Historical Financial Ratios
| NXGL Stock | USD 3.32 0.09 2.79% |
Nexgel is lately reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 59.33 will help investors to properly organize and evaluate Nexgel Inc financial condition quickly.
Nexgel |
About Nexgel Financial Ratios Analysis
Nexgel IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nexgel investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nexgel financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nexgel history.
Nexgel Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nexgel Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nexgel sales, a figure that is much harder to manipulate than other Nexgel Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Nexgel's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nexgel Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Nexgel's Cash Per Share is quite stable compared to the past year. Capex Per Share is expected to rise to 0.13 this year, although the value of PTB Ratio will most likely fall to 2.44.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 49.18 | 39.57 | 56.5 | 59.33 | PTB Ratio | 1.2 | 0.91 | 2.57 | 2.44 |
Nexgel fundamentals Correlations
Click cells to compare fundamentals
Nexgel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nexgel fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 66.62 | 544.59 | 9.38 | 3.4 | 2.95 | 2.81 | |
| Ptb Ratio | 125.71 | 5.2K | 1.2 | 0.91 | 2.57 | 2.44 | |
| Days Sales Outstanding | 51.92 | 39.53 | 49.18 | 39.57 | 56.5 | 59.33 | |
| Book Value Per Share | 0.028 | 6.81E-4 | 2.17 | 1.37 | 0.91 | 0.48 | |
| Free Cash Flow Yield | (0.038) | (0.005757) | (0.21) | (0.44) | (0.33) | (0.34) | |
| Operating Cash Flow Per Share | (0.13) | (0.0173) | (0.49) | (0.54) | (0.57) | (0.6) | |
| Stock Based Compensation To Revenue | 0.005579 | 0.34 | 0.18 | 0.15 | 0.0531 | 0.08 | |
| Pb Ratio | 125.71 | 5.2K | 1.2 | 0.91 | 2.57 | 2.44 | |
| Ev To Sales | 67.54 | 546.44 | 3.52 | 3.88 | 2.98 | 2.83 | |
| Free Cash Flow Per Share | (0.13) | (0.0203) | (0.54) | (0.55) | (0.69) | (0.73) | |
| Roic | (3.1) | (4.2) | (0.26) | (0.53) | (0.63) | (0.66) | |
| Inventory Turnover | 7.56 | 4.14 | 5.3 | 3.57 | 2.63 | 2.5 | |
| Net Income Per Share | (0.14) | (0.0219) | (1.13) | (1.1) | (0.56) | (0.58) | |
| Days Of Inventory On Hand | 48.3 | 88.13 | 68.88 | 102.25 | 138.74 | 145.68 | |
| Payables Turnover | 1.67 | 1.47 | 6.07 | 6.76 | 2.81 | 2.67 | |
| Pocfratio | (26.33) | (203.81) | (5.28) | (2.33) | (3.73) | (3.92) | |
| Pfcf Ratio | (26.33) | (173.71) | (4.81) | (2.26) | (3.07) | (3.23) | |
| Days Payables Outstanding | 217.97 | 248.88 | 60.12 | 53.98 | 129.7 | 78.06 | |
| Roe | (5.06) | (32.14) | (0.52) | (0.8) | (0.67) | (0.71) | |
| Ev To Operating Cash Flow | (26.69) | (204.5) | (1.98) | (2.66) | (3.76) | (3.95) | |
| Pe Ratio | (24.84) | (160.85) | (2.31) | (1.13) | (3.83) | (4.02) | |
| Return On Tangible Assets | (1.02) | (1.2) | (0.38) | (0.61) | (0.37) | (0.39) | |
| Ev To Free Cash Flow | (26.69) | (174.3) | (1.81) | (2.57) | (3.1) | (3.25) | |
| Earnings Yield | (0.0403) | (0.006217) | (0.43) | (0.88) | (0.26) | (0.27) | |
| Current Ratio | 0.64 | 0.27 | 4.82 | 8.74 | 1.98 | 1.9 | |
| Tangible Book Value Per Share | 0.028 | (0.002752) | 2.11 | 1.31 | 0.65 | 0.44 | |
| Receivables Turnover | 65.09 | 7.03 | 9.23 | 7.42 | 6.46 | 6.14 | |
| Graham Number | 0.3 | 0.0183 | 7.43 | 5.83 | 3.22 | 1.91 | |
| Shareholders Equity Per Share | 0.028 | 6.81E-4 | 2.17 | 1.37 | 0.83 | 0.47 | |
| Graham Net Net | (0.0822) | (0.019) | 1.57 | 0.77 | (0.17) | (0.16) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 0.846 | Quarterly Revenue Growth 0.234 | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.